Drug comparisons
Ubrogepant vs Zolmitriptan
Compare Ubrogepant (Ubrelvy) vs Zolmitriptan (Zomig) for acute migraine treatment. Ubrogepant is a CGRP receptor antagonist with no vasoconstriction, while Zolmitriptan is a triptan serotonin agonist. Both oral Rx options suit different patient profiles, especially cardiovascular risks.
No comparison dimensions are available for this page.
Clinical context
Patients experiencing acute migraines who do not respond adequately to triptans or have contraindications to vasoconstrictive agents may trigger this comparison.
Bottom line
Both Ubrogepant and Zolmitriptan are effective oral treatments for acute migraine relief, with the best option varying by patient needs.
All medication comparisons